Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, the latest drugmaker to boost its U.S.

Merck says the expansion in Durham is part of more than $12 billion the company has invested in U.S. manufacturing and ...

Merck & Co. (MSD outside the U.S. and Canada) has just unveiled a brand-new, cutting-edge vaccine manufacturing facility at ...

In a decision signed Monday, North Carolina federal judge Kenneth Bell granted Merck’s motion to dismiss the claims of ...

According to Judge Kenneth Bell, there is a lack of evidence to conclude that Merck willingly misrepresented the safety of ...

Merck has launched a $1 billion vaccine manufacturing facility in Durham, North Carolina, as part of a $12 billion U.S.

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the opening of a new, $1 billion, 225,000-square-foot facility dedicated to vaccine manufacturing at its Durham ...

MSD has opened the doors of a $1 billion manufacturing facility at its site in Durham, North Carolina, that will be used to ...

House Republicans’ funding patch includes cutting funds for the Congressionally Directed Medical Research Programs, an agency ...

Backed by funding from the Gates Foundation, software company Psyon is running a pilot study of a game that aims to raise ...

The Trump administration seized on a better-than-expected Consumer Price Index (CPI) report Wednesday to herald a trifecta of ...

近日，北卡罗莱纳州（North Carolina ）联邦法院法官Kenneth Bell驳回了200起针对HPV疫苗Gardasil的多区诉讼，裁定默沙东胜诉。 Kenneth Bell认为，没有足够证据证明Gardasil与原告声称的副作用之间存在因果关系。另外其指出，根据联邦法律，默沙东无权在未经FDA批准的情况下在Gardasil标签上添加安全风险警告。